BioMarin Genetics Inc. (Novato, California)

BioMarin Announces the Planned Retirement of Dr. Emil Kakkis, Chief Medical Officer.
PR Newswire; 11/21/2008; 1317 words; NOVATO, Calif...FirstCall/ -- BioMarin Pharmaceutical Inc. today announced...particularly, the BioMarin employees that...to joining BioMarin, he was an...Division of Genetics, Department...University of California at Los Angeles...

Kuvan, Naglazyme and Aldurazyme Data to Be Presented at the 57th Annual Meeting of the American Society of Human Genetics.
PR Newswire; 10/17/2007; 1311 words; NOVATO, Calif., Oct...FirstCall/ -- BioMarin Pharmaceutical Inc. (Nasdaq and SWX...Society of Human Genetics in San Diego, California, October 23-27...Munoz-Rojas) About BioMarin BioMarin develops and commercializes...

BioMarin and Serono Announce Data on Phenoptin in PKU to be Presented at the 56th Annual Meeting of the American Society of Human Genetics.
PR Newswire; 9/12/2006; 2756 words; NOVATO, California, and GENEVA, Switzerland...PRNewswire-FirstCall/ -- BioMarin Pharmaceutical Inc. and Serono (virt...American Society of Human Genetics (ASHG) being held...in PKU Results from a BioMarin-sponsored meta-analysis...

Genzyme, BioMarin Receive Marketing Approval for Aldurazyme in European Union.
PR Newswire; 6/11/2003; 2090 words; ...Genzyme General and BioMarin Pharmaceutical Inc. (Nasdaq and...Willink Biochemical Genetics Unit in Manchester...was developed by BioMarin and Genzyme under...manufactured at BioMarin's plant in Novato, California, USA, which has...

BioMarin Presents Positive Phase II Data on Aryplase for MPS VI; Aryplase(TM) Well Tolerated and Associated with Functional Improvements.
PR Newswire; 3/14/2003; 1661 words; -- BioMarin to Initiate...Trial in 2003 NOVATO, Calif...FirstCall/ -- BioMarin Pharmaceutical Inc. (Nasdaq...Oakland, California will present...of Medical Genetics 9th Annual Clinical Genetics Meeting in San Diego, California. The open...